Sanofi and GSK will provide up to 300 million doses of COVID-19 vaccine to the European Union
(WorldNews France)

Media Update Sanofi and GSK will provide up to 300 million doses of COVID-19 vaccine to the European Union Agreement signed today supports scale-up of manufacturing capabilities in several European countries Vaccine candidate uses Sanofi`s recombinant protein-based technology combined with GSK`s pandemic adjuvant system POSTED ON SEPTEMBER 18, 2020 Sanofi and GSK finalized and signed today an Advanced purchase agreement with the European Commission (EC) for the supply of up to 300 million doses of a COVID-19 vaccine, once the vaccine is approved. The vaccine candidate is based on the recombinant protein-based technology used by Sanofi to produce an influenza vaccine, and GSK`s established...